Medicinal Mushrooms
From Ancient Tonics to the Oncology Ward
Evidence grade 2 of 5, Thin. Read how the Atlas grades evidence.
The evidence is genuinely a spectrum, which is the honest story. At the strong end: PSK (krestin), a turkey-tail polysaccharide, is an approved adjuvant cancer therapy in Japan, used alongside conventional treatment for decades with supportive trial and meta-analysis data; lentinan (from shiitake) is similarly used as a cancer adjunct. At the emerging end: lion's mane has small human trials suggesting benefit for mild cognitive impairment (one well-cited 16-week study) and mixed signals for mood, and reishi/cordyceps have early data for immune markers, fatigue, and metabolic health. At the weak end: much of the "shroom boom" marketing rests on petri-dish and inbred-mouse studies that do not transfer cleanly to people, with small, unreplicated human trials. The summary: a few validated clinical uses (notably PSK/lentinan as oncology adjuncts), promising but unproven cognitive and adaptogenic claims, and a lot of market hype outrunning the data.
Reference only. Not medical advice.
What can go wrong
Standardized mushroom extracts at studied doses are generally well tolerated, with serious adverse events uncommon and no major liver or blood toxicity reported for the well-studied immune mushrooms; mild nausea, digestive upset, and rare skin reactions occur. The practical cautions matter more than acute toxicity. Immune-modulating mushrooms warrant care for people with autoimmune conditions or on immunosuppressant medication. Anyone in cancer care should use these only in coordination with their oncology team and never as a substitute for treatment; the Japanese evidence is for adjuncts added to chemotherapy, not replacements for it. Product quality varies widely, since mycelium-on-grain powders and fruiting-body extracts differ greatly and mislabeling occurs. Foraged wild mushrooms carry serious misidentification risk. Anyone pregnant or breastfeeding, and anyone weighing these for a diagnosed condition or for changes in memory or mood, should talk with a qualified healthcare provider before use rather than relying on retail claims. The biggest danger is treating an unproven immune or brain mushroom as a stand-in for real medical care.
Mushrooms are among the most revered medicines in East Asia, where reishi was called the herb of spiritual potency, cordyceps served as a vitality tonic, and shiitake, turkey tail, and lion's mane each carried classical roles in tonics taken over years for resilience. The modern picture runs across the whole evidence range and is worth holding honestly. At the strong end, PSK from turkey tail and lentinan from shiitake are licensed cancer adjuncts in Japan with real trial support when added to chemotherapy. In the middle, lion's mane has one small, much-cited cognition trial and reishi and cordyceps show early immune and exercise signals from small studies. At the weak end, most retail immune and brain claims rest on petri-dish and mouse work that does not carry over to people cleanly. Product quality and coordination with a cancer team are the practical cautions that matter most.
Ancient East Asian tonics now spanning the full evidence spectrum, from an approved Japanese cancer adjunct to "shroom boom" hype that outruns the data.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
How it is supposed to work
Mushrooms contain bioactive compounds with real pharmacology: beta-glucans and protein-bound polysaccharides (PSK, PSP, lentinan) that modulate immune function; in lion's mane, hericenones and erinacines that stimulate nerve growth factor; in cordyceps, cordycepin. These give plausible bases for immune, anti-tumor-adjuvant, and neurotrophic effects, though potency varies enormously by species, strain, extract, and preparation.
What people get wrong
Often saidMedicinal mushrooms are unproven folk magic with no real basis.
ActuallySome are genuinely validated. PSK from turkey tail and lentinan from shiitake are licensed cancer adjuncts in Japan. A 2022 Cochrane review of PSK in colorectal cancer (7 RCTs, 1,569 people) found a small five-year survival benefit at low certainty, and Wang 2017 pooled 17 lentinan studies (1,423 patients) showing better 1-year survival. The category is real even where individual product claims outrun the data.
Often saidAny mushroom supplement will boost immunity or brainpower as advertised.
ActuallyMost retail immune and brain claims rest on lab and mouse studies with few, small, unreplicated human trials. The much-cited Mori 2009 lion's mane trial had 30 people and its cognitive gains faded once dosing stopped, per the Alzheimer's Drug Discovery Foundation's review.
Often saidA bottle labeled reishi or cordyceps contains what the name implies.
ActuallyIndependent testing tells a different story. Analyses summarized by the extract supplier Nammex found whole fruiting bodies carrying roughly 25 to 40 percent beta-glucans and under 3 percent starch, while many US mycelium-on-grain products tested at 1 to 15 percent beta-glucans and 35 to 66 percent residual grain starch. One product sold as cordyceps measured about 1.5 percent beta-glucans.
Often saidForaging your own medicinal mushrooms is safe and natural.
ActuallyWild collection carries real misidentification risk, and even chaga is a birch fungus, not a true fruiting mushroom, with its own sourcing and heavy-metal concerns. Identification errors with lookalike species can be serious.
Who profits, and who pushes back
Japanese oncology
Uses turkey-tail PSK and shiitake lentinan as approved adjuncts alongside conventional cancer therapy, backed by decades of trials and meta-analyses.
Cognitive-trial researchers
Report small human trials suggesting benefit for mild cognitive impairment and mixed mood signals, while stressing the studies are small and need replication.
Mycology & food-science experts
Note that much promising data is from petri dishes and inbred rodents, may not transfer to people, and that long-term human trials are still needed.
Functional-mushroom marketing
Sells this. Has a commercial interest in a product sold as this compound, as of July 2026.
Promotes reishi, lion's mane, cordyceps, and chaga products with broad immunity, brain, and energy claims that outrun the human evidence, with a clear commercial interest.
Where the research comes from
Most of the published research on this comes from one place. 90% of it is from China (TCM materia medica). Findings that no unrelated group has reproduced are weaker than the study count makes them look.
| Place | Share of published research |
|---|---|
| China (TCM materia medica) | 90% |
| Japan & Korea | 82% |
| Global supplement market | 75% |
| Siberia & N. Europe (chaga) | 55% |
How we got here
Mushrooms appear in the oldest East Asian materia medica. Reishi, lingzhi in Chinese, was listed among the superior tonics in the Shennong Bencaojing, a text compiled around the first to second centuries and later preserved and annotated by the physician Tao Hongjing during the Liang period. Chinese, Japanese, and Korean traditions used reishi, shiitake, cordyceps, and others as slow tonics for vitality and long life. Far to the north, Khanty and other Siberian peoples, along with communities across Scandinavia and eastern Europe, steeped chaga from birch trees for stomach and other ailments from at least the sixteenth century. The clinical chapter opened in twentieth-century Japan, where researchers isolated the polysaccharides PSK from turkey tail and lentinan from shiitake and brought them into oncology as adjuncts. In the 2010s and 2020s a global wellness market revived the wider category, its marketing running well ahead of the evidence for most retail products.
- 1st-2nd c.Reishi (lingzhi) listed among superior tonics in the Shennong Bencaojing; later annotated by Tao Hongjing
- 16th c.Chaga documented as a folk remedy among Khanty and other Siberian peoples for stomach and other ailments
- 1969-1980sPSK (Krestin) from turkey tail developed in Japan and approved there as a cancer treatment adjunct
- 1985Lentinan from shiitake approved in Japan as an injectable adjunct alongside chemotherapy for gastric cancer
- 2009Mori double-blind trial reports cognitive gains from lion's mane in 30 people with mild cognitive impairment
- 2016Jin Cochrane review of reishi (5 RCTs) finds very low-quality evidence, not first-line
- 2017FDA warns 14 companies over 65-plus fraudulent cancer products, including herbal and supplement sellers
- 2022Cochrane review of turkey tail PSK (7 RCTs, 1,569 people) finds low-certainty small five-year survival benefit in colorectal cancer
How it is understood
Mushrooms occupy a revered place in East Asian medicine. Reishi (lingzhi in China, "mushroom of immortality") is the most prized fungus in the Chinese pharmacopoeia, described in classical texts as a tonic for the spirit (shen); cordyceps was a precious tonic for vitality and endurance; shiitake, turkey tail (yunzhi), and lion's mane each carried specific roles. The framing was holistic, mushrooms "tonified qi," calmed the mind, or supported organs, and they were taken as teas, decoctions, and tonics over long periods for resilience and longevity rather than as quick cures. Chaga has parallel folk roots in Siberia and northern Europe. Today the same fungi anchor a booming global "functional mushroom" market of powders, lattes, and capsules.
At a glance
- Most prized
- Reishi (lingzhi)
- Strongest evidence
- PSK (turkey tail), Japanese cancer adjunct
- Cognitive interest
- Lion's mane (small trials)
- Caveat
- Much research is lab/mouse, not people
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Medicinal Mushrooms. A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
Sources
PSK/turkey tail in colorectal cancer: small low-certainty five-year survival benefit (RR 1.08), adverse-effect data very low certainty; 7 RCTs, 1,569 participants
Cochrane Database of Systematic Reviews (Eastwood et al., 2022; PMC mirror)
Lentinan with chemotherapy improves 1-year survival (RR 1.46, P=0.001) and response (RR 1.28, P=0.005); 17 studies, 1,423 patients; no 2-year survival difference
Reishi Cochrane review: 5 RCTs, 373 people, very low quality; not justified as first-line, adjunct could be considered, long-term survival uncertain; CD3/CD4/CD8 rises, NK insignificant
Cochrane Database of Systematic Reviews (Jin et al., 2016; PMC mirror)
Lion's mane: small, short, inconsistent trials; Mori 2009 gains faded after treatment stopped; 7 RCTs identified; foundation calls evidence unconvincing
Cordyceps sinensis Cs-4 improved VO2max and threshold in older adults (Chen 2010, n=20; and Xiao trial n=37); signals small and mixed
Journal of Alternative and Complementary Medicine (Chen et al. 2010, PMC)
MSK on Coriolus/PSK: developed in Japan, appears to improve survival as adjuvant, but not FDA-approved and many OTC products not standardized; inform providers
Memorial Sloan Kettering Cancer Center, Integrative Medicine
Beta-glucan/starch gap: fruiting bodies roughly 25-40% beta-glucans, under 3% starch; mycelium-on-grain 1-15% beta-glucans, 35-66% grain starch; cordyceps product ~1.5% beta-glucans
Nammex, Redefining Medicinal Mushrooms (extract supplier report of lab testing)
FDA regulatory posture and 2017 action: supplements not approved to treat cancer; 14 companies warned over 65-plus fraudulent cancer products
Reishi (lingzhi) history: listed among superior tonics in the Shennong Bencaojing, later annotated by Tao Hongjing (Liang period)
Springer, Ganoderma (Lingzhi) in Traditional Chinese Medicine and Chinese Culture
Chaga (Inonotus obliquus) folk use among Khanty and Siberian/eastern European peoples from the 16th century; polypores among Otzi's tools
European medicinal polypores: a modern view on traditional uses, J. Ethnopharmacology
Shennong Bencaojing dating and structure (first-second century compilation; 120 superior drugs)
FDA warning letters citing mushroom products for illegal disease/cancer claims (e.g., Desert Alchemist cordyceps, 2020)